시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 암 지지요법 제품 시장 보고서(2025년)
Cancer Supportive Care Products Global Market Report 2025
상품코드 : 1703037
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,339,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,163,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,987,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

암 지지요법 제품 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보이며 2029년까지 연평균 4.8%의 성장률로 273억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 암 유병률 증가, 환자 중심 접근법 증가, 암 연구에 대한 투자 증가, 맞춤 의료에 대한 관심 증가, 암 생존율 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 발전, 첨단 약물 전달 시스템, 신약 제제, 개인 맞춤형 의료, 생분해성 제품 개발 등을 들 수 있습니다.

암 발병률 증가는 향후 암 지지요법 제품 시장의 성장을 견인할 것으로 예측됩니다. 인구 고령화에 따라 세포의 변화와 다양한 위험 요인에 장기간 노출되면 암 발생 위험이 높아집니다. 또한, 흡연, 식습관 장애, 운동 부족, 과도한 알코올 섭취와 같은 생활습관 요인도 암 위험에 크게 기여하고 있습니다. 암 지지요법 제품은 증상을 관리하고, 삶의 질을 개선하며, 치료 중인 환자를 지원하도록 설계되어 암 발병률 증가에 따른 수요 증가에 대응하고 있습니다. 예를 들어, 2024년 1월 미국 암 퇴치 비영리단체인 미국암협회는 2024년 구강 및 인두암 환자 수를 5,8,450명으로 예측했으며, 이는 2023년 보고된 5,4,540명보다 7.2% 증가한 수치입니다. 이에 따라 암 발병률 증가가 암 지지요법 제품 시장의 성장을 가속할 것으로 예측됩니다.

암 지지요법 제품 시장의 주요 기업들은 치료 효과 향상, 부작용 감소, 환자 예후 개선을 위해 표적 방사성 리간드 요법(RLT) 플랫폼과 같은 혁신 기술을 개발하고 있으며, RLT 플랫폼은 암세포 마커에 특이적으로 결합하는 방사성 표지 분자를 사용하여 표적 방사선을 조사하여 표적 방사선을 조사하여 건강한 조직을 보존하면서 암세포를 파괴합니다. 예를 들어, 2022년 5월 스위스 제약사 노바티스(Novartis AG)는 이전 치료에 반응하지 않는 전립선 특이적 막항원 양성 전이성 거세저항성 전립선암(PSMA 양성 mCRPC)의 치료제로 플루빅토(lutetium Lu 177 vipivotide tetraxetan)의 FDA 승인을 받았습니다. 플루빅토는 FDA가 승인한 최초의 방사성 동위원소 표적 치료제로, 표적 리간드와 치료용 방사성 동위원소를 결합한 약물입니다. 또한, FDA는 PET 검사에서 PSMA 양성 병변을 검출하는 데 사용되는 Locametz(갈륨 Ga68 고세토티드 주사제)를 승인하여 암의 확산을 확인하고 플루빅토 치료의 적합성 여부를 판단하는 데 도움을 주고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Cancer supportive care products encompass a range of medical treatments, therapies, and products designed to manage and alleviate the symptoms, side effects, and complications associated with cancer and its treatments. These products aim to enhance the quality of life for cancer patients by providing physical, emotional, and psychological support.

Key categories of drugs in cancer supportive care include nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infective drugs, anti-emetics, monoclonal antibodies, erythropoietin-stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony-stimulating factors. NSAIDs, for example, help reduce inflammation, pain, and fever by inhibiting enzymes involved in the inflammatory process, which assists in managing pain and discomfort related to cancer and its treatments. These products are used for various types of cancer, including lung, breast, prostate, liver, bladder, leukemia, ovarian, and melanoma cancers. They are distributed through hospital pharmacies, retail pharmacies, and compounding pharmacies.

The cancer supportive care products market research report is one of a series of new reports from the business research company that provides cancer supportive care products market statistics, including cancer supportive care products industry global market size, regional shares, competitors with an cancer supportive care products market share, detailed cancer supportive care products market segments, market trends and opportunities, and any further data you may need to thrive in the cancer supportive care products industry. This cancer supportive care products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer supportive care products market size has grown strongly in recent years. It will grow from $21.56 billion in 2024 to $22.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to growing cancer incidence, increased awareness and education, improved healthcare infrastructure, a growing geriatric population, increased awareness, and early detection.

The cancer supportive care products market size is expected to see steady growth in the next few years. It will grow to $27.32 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the rising prevalence of cancer, growing patient-centric approaches, growing investment in cancer research, a rising focus on personalized medicine, and rising cancer survival rates. Major trends in the forecast period include technological advancements, advanced drug delivery systems, new drug formulations, personalized care, and the and the development of biodegradable products.

The growing incidence of cancer is expected to drive the expansion of the cancer supportive care products market in the future. As populations age, the risk of cancer increases due to cellular changes and prolonged exposure to various risk factors. Additionally, lifestyle factors such as smoking, poor diet, insufficient physical activity, and excessive alcohol consumption contribute significantly to cancer risk. Cancer supportive care products are designed to manage symptoms, enhance quality of life, and support patients undergoing treatment, addressing the increasing need due to the rising cancer rates. For example, in January 2024, the American Cancer Society, a US-based non-profit organization focused on cancer elimination, projected 58,450 cases of oral cavity and pharynx cancer, marking a 7.2% increase from the 54,540 cases reported in 2023. Consequently, the rising incidence of cancer is expected to propel the growth of the cancer supportive care products market.

Leading companies in the cancer supportive care products market are working on innovations such as targeted radioligand therapy (RLT) platforms to improve treatment effectiveness, reduce side effects, and enhance patient outcomes. RLT platforms use radiolabeled molecules that specifically bind to cancer cell markers to deliver targeted radiation, destroying cancer cells while preserving healthy tissue. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that has not responded to previous treatments. Pluvicto is the first FDA-approved targeted radioligand therapy for this condition, combining a targeting ligand with a therapeutic radioisotope. Additionally, the FDA approved Locametz (gallium Ga 68 gozetotide injection), used in PET scans to detect PSMA-positive lesions, aiding in the identification of cancer spread and determining suitability for Pluvicto treatment.

In October 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired POINT Biopharma Global Inc. for an undisclosed sum. This acquisition aims to enhance Eli Lilly's capabilities in targeted radiopharmaceuticals for cancer treatment. POINT Biopharma Global Inc., a US-based biotechnology company, focuses on developing and commercializing radiopharmaceuticals for targeted cancer therapies.

Major companies operating in the cancer supportive care products market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Limited, Baxter International Inc., Daiichi Sankyo Company Limited, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Kyowa Hakko Kirin Co. Ltd., QIAGEN N.V., Exelixis Inc., Fagron Group B.V., Tessa Therapeutics Pte Ltd., Mirati Therapeutics Inc., APR Applied Pharma Science Research S.A., Acacia Pharma Ltd., Arquer Diagnostics Ltd.

North America was the largest region in the cancer supportive care products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer supportive care products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer supportive care products market consists of sales of medications, nutritional supplements, pain management products, and therapeutic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Supportive Care Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer supportive care products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cancer supportive care products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer supportive care products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Subsegments

Table of Contents

1. Executive Summary

2. Cancer Supportive Care Products Market Characteristics

3. Cancer Supportive Care Products Market Trends And Strategies

4. Cancer Supportive Care Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Supportive Care Products Growth Analysis And Strategic Analysis Framework

6. Cancer Supportive Care Products Market Segmentation

7. Cancer Supportive Care Products Market Regional And Country Analysis

8. Asia-Pacific Cancer Supportive Care Products Market

9. China Cancer Supportive Care Products Market

10. India Cancer Supportive Care Products Market

11. Japan Cancer Supportive Care Products Market

12. Australia Cancer Supportive Care Products Market

13. Indonesia Cancer Supportive Care Products Market

14. South Korea Cancer Supportive Care Products Market

15. Western Europe Cancer Supportive Care Products Market

16. UK Cancer Supportive Care Products Market

17. Germany Cancer Supportive Care Products Market

18. France Cancer Supportive Care Products Market

19. Italy Cancer Supportive Care Products Market

20. Spain Cancer Supportive Care Products Market

21. Eastern Europe Cancer Supportive Care Products Market

22. Russia Cancer Supportive Care Products Market

23. North America Cancer Supportive Care Products Market

24. USA Cancer Supportive Care Products Market

25. Canada Cancer Supportive Care Products Market

26. South America Cancer Supportive Care Products Market

27. Brazil Cancer Supportive Care Products Market

28. Middle East Cancer Supportive Care Products Market

29. Africa Cancer Supportive Care Products Market

30. Cancer Supportive Care Products Market Competitive Landscape And Company Profiles

31. Cancer Supportive Care Products Market Other Major And Innovative Companies

32. Global Cancer Supportive Care Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Supportive Care Products Market

34. Recent Developments In The Cancer Supportive Care Products Market

35. Cancer Supportive Care Products Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기